WEDGE CAPITAL MANAGEMENT L L P/NC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 144 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
WEDGE CAPITAL MANAGEMENT L L P/NC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$62
-99.9%
31,2030.0%0.00%0.0%
Q3 2022$63,000
-36.4%
31,2030.0%0.00%
-50.0%
Q2 2022$99,000
-20.8%
31,203
+3.9%
0.00%0.0%
Q1 2022$125,000
-12.6%
30,027
+0.7%
0.00%0.0%
Q4 2021$143,000
+16.3%
29,813
+29.3%
0.00%0.0%
Q3 2021$123,000
+29.5%
23,050
+23.9%
0.00%
+100.0%
Q2 2021$95,00018,6020.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders